{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T13:34:59Z","timestamp":1785764099825,"version":"3.56.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T00:00:00Z","timestamp":1748908800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T00:00:00Z","timestamp":1748908800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"City of Vienna Fund for Innovative Interdisciplinary Cancer Research","award":["21021"],"award-info":[{"award-number":["21021"]}]},{"DOI":"10.13039\/501100004955","name":"\u00d6sterreichische Forschungsf\u00f6rderungsgesellschaft","doi-asserted-by":"crossref","award":["880603"],"award-info":[{"award-number":["880603"]}],"id":[{"id":"10.13039\/501100004955","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004955","name":"\u00d6sterreichische Forschungsf\u00f6rderungsgesellschaft","doi-asserted-by":"crossref","award":["880603"],"award-info":[{"award-number":["880603"]}],"id":[{"id":"10.13039\/501100004955","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-01917-z","type":"journal-article","created":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T02:32:48Z","timestamp":1748917968000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["High CD36 expression in the tumor microenvironmental vasculature correlates with unfavorable overall survival in high grade serous ovarian cancer"],"prefix":"10.1038","volume":"15","author":[{"given":"Christina T.","family":"Grech","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Aust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerda","family":"Hofstetter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Uhl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenz","family":"Hinterleitner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Grimm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Polterauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dietmar","family":"Pils","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,3]]},"reference":[{"key":"1917_CR1","unstructured":"Statistik Austria. Krebserkrankungen in \u00d6sterreich 2020. Vienna."},{"key":"1917_CR2","unstructured":"Center, G. C. R. Ovarian cancer Survival in Germany: an Nationwide Analysis by Stage and Histotype (Robert Koch-Institut, 2024)."},{"issue":"3","key":"1917_CR3","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/s41590-019-0589-5","volume":"21","author":"H Wang","year":"2020","unstructured":"Wang, H. et al. CD36-mediated metabolic adaptation supports regulatory T cell survival and function in tumors. Nat. Immunol. 21 (3), 298\u2013308 (2020).","journal-title":"Nat. Immunol."},{"issue":"17","key":"1917_CR4","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1038\/s41388-017-0093-z","volume":"37","author":"A Ladanyi","year":"2018","unstructured":"Ladanyi, A. et al. Adipocyte-induced CD36 expression drives ovarian cancer progression and metastasis. Oncogene 37 (17), 2285\u20132301 (2018).","journal-title":"Oncogene"},{"issue":"17","key":"1917_CR5","doi-asserted-by":"publisher","first-page":"4893","DOI":"10.7150\/thno.36037","volume":"9","author":"J Wang","year":"2019","unstructured":"Wang, J. & Li, Y. CD36 Tango in cancer: signaling pathways and functions. Theranostics 9 (17), 4893\u20134908 (2019).","journal-title":"Theranostics"},{"issue":"1","key":"1917_CR6","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/BF00231876","volume":"133","author":"CM Harmon","year":"1993","unstructured":"Harmon, C. M. & Abumrad, N. A. Binding of sulfosuccinimidyl fatty acids to adipocyte membrane proteins: isolation and amino-terminal sequence of an 88-kD protein implicated in transport of long-chain fatty acids. J. Membr. Biol. 133 (1), 43\u201349 (1993).","journal-title":"J. Membr. Biol."},{"issue":"4","key":"1917_CR7","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1161\/CIRCRESAHA.118.313237","volume":"123","author":"X Pi","year":"2018","unstructured":"Pi, X., Xie, L. & Patterson, C. Emerging roles of vascular endothelium in metabolic homeostasis. Circul. Res. 123 (4), 477\u2013494 (2018).","journal-title":"Circul. Res."},{"issue":"5","key":"1917_CR8","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144 (5), 646\u2013674 (2011).","journal-title":"Cell"},{"key":"1917_CR9","doi-asserted-by":"crossref","unstructured":"Kimmelman, A. C. & Sherman, M. H. The role of stroma in Cancer metabolism. Cold Spring Harb Perspect. Med. ;14(5). (2024).","DOI":"10.1101\/cshperspect.a041540"},{"issue":"11","key":"1917_CR10","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1038\/nm.2492","volume":"17","author":"KM Nieman","year":"2011","unstructured":"Nieman, K. M. et al. Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth. Nat. Med. 17 (11), 1498\u20131503 (2011).","journal-title":"Nat. Med."},{"issue":"5","key":"1917_CR11","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.cmet.2016.10.011","volume":"24","author":"L Yang","year":"2016","unstructured":"Yang, L. et al. Targeting stromal glutamine synthetase in tumors disrupts tumor Microenvironment-Regulated Cancer cell growth. Cell. Metab. 24 (5), 685\u2013700 (2016).","journal-title":"Cell. Metab."},{"issue":"56","key":"1917_CR12","doi-asserted-by":"publisher","first-page":"96035","DOI":"10.18632\/oncotarget.21635","volume":"8","author":"W Li","year":"2017","unstructured":"Li, W. et al. TGFbeta1 in fibroblasts-derived exosomes promotes epithelial-mesenchymal transition of ovarian cancer cells. Oncotarget 8 (56), 96035\u201396047 (2017).","journal-title":"Oncotarget"},{"issue":"1","key":"1917_CR13","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s13045-024-01600-2","volume":"17","author":"F Zhang","year":"2024","unstructured":"Zhang, F. et al. Cancer associated fibroblasts and metabolic reprogramming: unraveling the intricate crosstalk in tumor evolution. J. Hematol. Oncol. 17 (1), 80 (2024).","journal-title":"J. Hematol. Oncol."},{"issue":"2","key":"1917_CR14","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1158\/0008-5472.CAN-14-1337","volume":"75","author":"B Salimian Rizi","year":"2015","unstructured":"Salimian Rizi, B. et al. Nitric oxide mediates metabolic coupling of omentum-derived adipose stroma to ovarian and endometrial cancer cells. Cancer Res. 75 (2), 456\u2013471 (2015).","journal-title":"Cancer Res."},{"issue":"7635","key":"1917_CR15","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nature20791","volume":"541","author":"G Pascual","year":"2017","unstructured":"Pascual, G. et al. Targeting metastasis-initiating cells through the fatty acid receptor CD36. Nature 541 (7635), 41\u201345 (2017).","journal-title":"Nature"},{"issue":"3","key":"1917_CR16","doi-asserted-by":"publisher","first-page":"e57911","DOI":"10.1371\/journal.pone.0057911","volume":"8","author":"SM Rachidi","year":"2013","unstructured":"Rachidi, S. M., Qin, T., Sun, S., Zheng, W. J. & Li, Z. Molecular profiling of multiple human cancers defines an inflammatory cancer-associated molecular pattern and uncovers KPNA2 as a uniform poor prognostic cancer marker. PloS One. 8 (3), e57911 (2013).","journal-title":"PloS One"},{"key":"1917_CR17","doi-asserted-by":"crossref","unstructured":"Westergaard, M. C. W. et al. Changes in the tumor immune microenvironment during disease progression in patients with ovarian Cancer. Cancers ;12(12). (2020).","DOI":"10.3390\/cancers12123828"},{"issue":"329","key":"1917_CR18","doi-asserted-by":"publisher","first-page":"329ra34","DOI":"10.1126\/scitranslmed.aad5653","volume":"8","author":"S Wang","year":"2016","unstructured":"Wang, S. et al. Development of a prosaposin-derived therapeutic Cyclic peptide that targets ovarian cancer via the tumor microenvironment. Sci. Transl. Med. 8 (329), 329ra34 (2016).","journal-title":"Sci. Transl. Med."},{"issue":"38","key":"1917_CR19","doi-asserted-by":"publisher","first-page":"61336","DOI":"10.18632\/oncotarget.11038","volume":"7","author":"K Auer","year":"2016","unstructured":"Auer, K. et al. Role of the immune system in the peritoneal tumor spread of high grade serous ovarian cancer. Oncotarget 7 (38), 61336\u201361354 (2016).","journal-title":"Oncotarget"},{"key":"1917_CR20","doi-asserted-by":"crossref","unstructured":"Muqaku, B. et al. Neutrophil extracellular trap formation correlates with favorable overall survival in high grade ovarian Cancer. Cancers ;12(2). (2020).","DOI":"10.3390\/cancers12020505"},{"key":"1917_CR21","doi-asserted-by":"crossref","unstructured":"Bekos, C. et al. NECTIN4 (PVRL4) as Putative Therapeutic Target for a Specific Subtype of High Grade Serous Ovarian Cancer-An Integrative Multi-Omics Approach. Cancers. ;11(5). (2019).","DOI":"10.3390\/cancers11050698"},{"issue":"1","key":"1917_CR22","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/75556","volume":"25","author":"M Ashburner","year":"2000","unstructured":"Ashburner, M. et al. Gene ontology: tool for the unification of biology. The gene ontology consortium. Nat. Genet. 25 (1), 25\u201329 (2000).","journal-title":"Nat. Genet."},{"key":"1917_CR23","unstructured":"Gene Ontology, C. et al. The gene ontology knowledgebase in 2023. Genetics ;224(1). (2023)."},{"key":"1917_CR24","doi-asserted-by":"crossref","unstructured":"Feng, W. W., Zuppe, H. T. & Kurokawa, M. The role of CD36 in Cancer progression and its value as a therapeutic target. Cells ;12(12). (2023).","DOI":"10.3390\/cells12121605"},{"key":"1917_CR25","doi-asserted-by":"crossref","unstructured":"Baczewska, M. et al. Energy substrate transporters in High-Grade ovarian cancer: gene expression and clinical implications. Int. J. Mol. Sci. 23(16). (2022).","DOI":"10.3390\/ijms23168968"},{"issue":"6220","key":"1917_CR26","doi-asserted-by":"publisher","first-page":"1260419","DOI":"10.1126\/science.1260419","volume":"347","author":"M Uhlen","year":"2015","unstructured":"Uhlen, M. et al. Proteomics. Tissue-based map of the human proteome. Science 347 (6220), 1260419 (2015).","journal-title":"Science"},{"issue":"52","key":"1917_CR27","doi-asserted-by":"publisher","first-page":"7945","DOI":"10.1038\/sj.onc.1205956","volume":"21","author":"T Hawighorst","year":"2002","unstructured":"Hawighorst, T. et al. Thrombospondin-1 selectively inhibits early-stage carcinogenesis and angiogenesis but not tumor lymphangiogenesis and lymphatic metastasis in Transgenic mice. Oncogene 21 (52), 7945\u20137956 (2002).","journal-title":"Oncogene"},{"issue":"1","key":"1917_CR28","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s13046-019-1049-7","volume":"38","author":"J Pan","year":"2019","unstructured":"Pan, J. et al. CD36 mediates palmitate acid-induced metastasis of gastric cancer via AKT\/GSK-3beta\/beta-catenin pathway. J. Exp. Clin. Cancer Res. 38 (1), 52 (2019).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"1917_CR29","doi-asserted-by":"crossref","unstructured":"Pardo, J. C. et al. Prognostic impact of CD36 immunohistochemical expression in patients with Muscle-Invasive bladder Cancer treated with cystectomy and adjuvant chemotherapy. J. Clin. Med. ;11(3). (2022).","DOI":"10.3390\/jcm11030497"},{"issue":"7","key":"1917_CR30","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1002\/stem.1716","volume":"32","author":"JS Hale","year":"2014","unstructured":"Hale, J. S. et al. Cancer stem cell-specific scavenger receptor CD36 drives glioblastoma progression. Stem Cells. 32 (7), 1746\u20131758 (2014).","journal-title":"Stem Cells"},{"issue":"1","key":"1917_CR31","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s12885-023-11771-9","volume":"24","author":"JS Enke","year":"2024","unstructured":"Enke, J. S. et al. SARIFA as a new histopathological biomarker is associated with adverse clinicopathological characteristics, tumor-promoting fatty-acid metabolism, and might predict a metastatic pattern in pT3a prostate cancer. BMC Cancer. 24 (1), 65 (2024).","journal-title":"BMC Cancer"},{"key":"1917_CR32","doi-asserted-by":"publisher","first-page":"6641","DOI":"10.2147\/CMAR.S183043","volume":"10","author":"J Wang","year":"2018","unstructured":"Wang, J. et al. Fibrosis of mesothelial cell-induced peritoneal implantation of ovarian cancer cells. Cancer Manage. Res. 10, 6641\u20136647 (2018).","journal-title":"Cancer Manage. Res."},{"issue":"9","key":"1917_CR33","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1016\/j.prp.2018.07.009","volume":"214","author":"L Hong","year":"2018","unstructured":"Hong, L., Wang, S., Li, W., Wu, D. & Chen, W. Tumor-associated macrophages promote the metastasis of ovarian carcinoma cells by enhancing CXCL16\/CXCR6 expression. Pathol. Res. Pract. 214 (9), 1345\u20131351 (2018).","journal-title":"Pathol. Res. Pract."},{"issue":"1","key":"1917_CR34","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.1038\/s41598-019-38766-6","volume":"9","author":"H Mir","year":"2019","unstructured":"Mir, H. et al. Higher CXCL16 exodomain is associated with aggressive ovarian cancer and promotes the disease by CXCR6 activation and MMP modulation. Sci. Rep. 9 (1), 2527 (2019).","journal-title":"Sci. Rep."},{"key":"1917_CR35","doi-asserted-by":"crossref","unstructured":"Ma, X. et al. CCL3 Promotes Proliferation of Colorectal Cancer Related with TRAF6\/NF-kappaB Molecular Pathway. Contrast Media Mol. Imaging. 2387192 (2022).","DOI":"10.1155\/2022\/2387192"},{"issue":"9","key":"1917_CR36","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1038\/s41374-020-0441-4","volume":"100","author":"T Kodama","year":"2020","unstructured":"Kodama, T. et al. CCL3-CCR5 axis contributes to progression of esophageal squamous cell carcinoma by promoting cell migration and invasion via Akt and ERK pathways. Lab. Invest. 100 (9), 1140\u20131157 (2020).","journal-title":"Lab. Invest."},{"issue":"1","key":"1917_CR37","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12967-023-03897-y","volume":"21","author":"S Zhou","year":"2023","unstructured":"Zhou, S. et al. CCL3 secreted by hepatocytes promotes the metastasis of intrahepatic cholangiocarcinoma by VIRMA-mediated N6-methyladenosine (m(6)A) modification. J. Translational Med. 21 (1), 43 (2023).","journal-title":"J. Translational Med."},{"key":"1917_CR38","doi-asserted-by":"crossref","unstructured":"Korbecki, J., Grochans, S., Gutowska, I., Barczak, K. & Baranowska-Bosiacka, I. CC chemokines in a tumor: A review of Pro-Cancer and Anti-Cancer properties of receptors CCR5, CCR6, CCR7, CCR8, CCR9, and CCR10 ligands. Int. J. Mol. Sci. 21(20). (2020).","DOI":"10.3390\/ijms21207619"},{"key":"1917_CR39","doi-asserted-by":"crossref","unstructured":"Qian, J. et al. Cancer-associated mesothelial cells promote ovarian cancer chemoresistance through paracrine osteopontin signaling. J. Clin. Investig. 131(16). (2021).","DOI":"10.1172\/JCI146186"},{"key":"1917_CR40","doi-asserted-by":"publisher","first-page":"736272","DOI":"10.3389\/fmolb.2021.736272","volume":"8","author":"J Yang","year":"2021","unstructured":"Yang, J. et al. A novel diagnostic biomarker, PZP, for detecting colorectal Cancer in type 2 diabetes mellitus patients identified by Serum-Based mass spectrometry. Front. Mol. Biosci. 8, 736272 (2021).","journal-title":"Front. Mol. Biosci."},{"issue":"1","key":"1917_CR41","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s12935-021-01861-8","volume":"21","author":"J Yang","year":"2021","unstructured":"Yang, J. et al. Discovery and validation of PZP as a novel serum biomarker for screening lung adenocarcinoma in type 2 diabetes mellitus patients. Cancer Cell Int. 21 (1), 162 (2021).","journal-title":"Cancer Cell Int."},{"issue":"12","key":"1917_CR42","first-page":"910","volume":"107","author":"H Teng","year":"1994","unstructured":"Teng, H., Zhang, W. Y. & Zhu, F. Q. A study on the serum pregnancy zone protein levels in pregnant women and patients with gynecological tumors. Chin. Med. J. 107 (12), 910\u2013914 (1994).","journal-title":"Chin. Med. J."},{"key":"1917_CR43","doi-asserted-by":"publisher","first-page":"112002","DOI":"10.1016\/j.biopha.2021.112002","volume":"142","author":"SA Jaberi","year":"2021","unstructured":"Jaberi, S. A. et al. Lipocalin-2: structure, function, distribution and role in metabolic disorders. Biomed. Pharmacother. 142, 112002 (2021).","journal-title":"Biomed. Pharmacother."},{"key":"1917_CR44","doi-asserted-by":"crossref","unstructured":"Camara-Quilez, M. et al. The HMGB1-2 ovarian Cancer interactome. The role of HMGB proteins and their interacting partners MIEN1 and NOP53 in ovary Cancer and Drug-Response. Cancers ;12(9). (2020).","DOI":"10.3390\/cancers12092435"},{"issue":"6","key":"1917_CR45","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.2353\/ajpath.2009.080960","volume":"174","author":"P Gutwein","year":"2009","unstructured":"Gutwein, P. et al. CXCL16 is expressed in podocytes and acts as a scavenger receptor for oxidized low-density lipoprotein. Am. J. Pathol. 174 (6), 2061\u20132072 (2009).","journal-title":"Am. J. Pathol."},{"key":"1917_CR46","doi-asserted-by":"crossref","unstructured":"Saorin, A., Di Gregorio, E., Miolo, G., Steffan, A. & Corona, G. Emerging role of metabolomics in ovarian Cancer diagnosis. Metabolites ;10(10). (2020).","DOI":"10.3390\/metabo10100419"},{"issue":"8","key":"1917_CR47","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1158\/1078-0432.CCR-16-1647","volume":"23","author":"A Bachmayr-Heyda","year":"2017","unstructured":"Bachmayr-Heyda, A. et al. Integrative systemic and local metabolomics with impact on survival in High-Grade serous ovarian Cancer. Clin. Cancer Res. 23 (8), 2081\u20132092 (2017).","journal-title":"Clin. Cancer Res."},{"key":"1917_CR48","doi-asserted-by":"crossref","unstructured":"Plewa, S. et al. Usefulness of amino acid profiling in ovarian Cancer screening with special emphasis on their role in cancerogenesis. Int. J. Mol. Sci. ;18(12). (2017).","DOI":"10.3390\/ijms18122727"},{"issue":"1","key":"1917_CR49","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1021\/pr3009572","volume":"12","author":"T Zhang","year":"2013","unstructured":"Zhang, T. et al. Identification of potential biomarkers for ovarian cancer by urinary metabolomic profiling. J. Proteome Res. 12 (1), 505\u2013512 (2013).","journal-title":"J. Proteome Res."},{"issue":"10","key":"1917_CR50","doi-asserted-by":"publisher","first-page":"5853","DOI":"10.1007\/s11033-013-2691-3","volume":"40","author":"A Hasim","year":"2013","unstructured":"Hasim, A. et al. Plasma-free amino acid profiling of cervical cancer and cervical intraepithelial neoplasia patients and its application for early detection. Mol. Biol. Rep. 40 (10), 5853\u20135859 (2013).","journal-title":"Mol. Biol. Rep."},{"key":"1917_CR51","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.lungcan.2016.04.008","volume":"100","author":"A Klupczynska","year":"2016","unstructured":"Klupczynska, A. et al. Evaluation of serum amino acid profiles\u2019 utility in non-small cell lung cancer detection in Polish population. Lung cancer. 100, 71\u201376 (2016).","journal-title":"Lung cancer"},{"issue":"9\u201310","key":"1917_CR52","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.cca.2012.01.026","volume":"413","author":"T Zhang","year":"2012","unstructured":"Zhang, T. et al. Discrimination between malignant and benign ovarian tumors by plasma metabolomic profiling using ultra performance liquid chromatography\/mass spectrometry. Clin. Chim. Acta. 413 (9\u201310), 861\u2013868 (2012).","journal-title":"Clin. Chim. Acta"},{"issue":"1","key":"1917_CR53","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s12276-020-0375-3","volume":"52","author":"EL Lieu","year":"2020","unstructured":"Lieu, E. L., Nguyen, T., Rhyne, S. & Kim, J. Amino acids in cancer. Exp. Mol. Med. 52 (1), 15\u201330 (2020).","journal-title":"Exp. Mol. Med."},{"issue":"1","key":"1917_CR54","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41416-020-0875-x","volume":"123","author":"CE Ford","year":"2020","unstructured":"Ford, C. E., Werner, B., Hacker, N. F. & Warton, K. The untapped potential of Ascites in ovarian cancer research and treatment. Br. J. Cancer. 123 (1), 9\u201316 (2020).","journal-title":"Br. J. Cancer"},{"issue":"4","key":"1917_CR55","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/nrc3432","volume":"13","author":"E Kipps","year":"2013","unstructured":"Kipps, E., Tan, D. S. & Kaye, S. B. Meeting the challenge of Ascites in ovarian cancer: new avenues for therapy and research. Nat. Rev. Cancer. 13 (4), 273\u2013282 (2013).","journal-title":"Nat. Rev. Cancer"},{"key":"1917_CR56","doi-asserted-by":"crossref","unstructured":"Capellero, S. et al. Ovarian Cancer cells in Ascites form aggregates that display a hybrid Epithelial-Mesenchymal phenotype and allows survival and proliferation of metastasizing cells. Int. J. Mol. Sci. ;23(2). (2022).","DOI":"10.3390\/ijms23020833"},{"issue":"19","key":"1917_CR57","doi-asserted-by":"publisher","first-page":"17261","DOI":"10.18632\/oncotarget.3746","volume":"6","author":"K Auer","year":"2015","unstructured":"Auer, K. et al. Peritoneal tumor spread in serous ovarian cancer-epithelial mesenchymal status and outcome. Oncotarget 6 (19), 17261\u201317275 (2015).","journal-title":"Oncotarget"},{"issue":"1","key":"1917_CR58","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28 (1), 27\u201330 (2000).","journal-title":"Nucleic Acids Res."},{"issue":"11","key":"1917_CR59","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1002\/pro.3715","volume":"28","author":"M Kanehisa","year":"2019","unstructured":"Kanehisa, M. Toward Understanding the origin and evolution of cellular organisms. Protein Sci. 28 (11), 1947\u20131951 (2019).","journal-title":"Protein Sci."},{"issue":"D1","key":"1917_CR60","doi-asserted-by":"publisher","first-page":"D672","DOI":"10.1093\/nar\/gkae909","volume":"53","author":"M Kanehisa","year":"2025","unstructured":"Kanehisa, M., Furumichi, M., Sato, Y., Matsuura, Y. & Ishiguro-Watanabe, M. KEGG: biological systems database as a model of the real world. Nucleic Acids Res. 53 (D1), D672\u2013D7 (2025).","journal-title":"Nucleic Acids Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-01917-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-01917-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-01917-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T15:01:54Z","timestamp":1749308514000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-01917-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,3]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1917"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-01917-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,3]]},"assertion":[{"value":"30 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was conducted in accordance with the guidelines of the Declaration of Helsinki and was approved by the Institutional Review Board of the Medical University of Vienna (1966\/2020 and 1892\/2021). All patients gave their written informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"19354"}}